Global /India /Healthcare /Medical Distribution /BALAXI

Balaxi Pharmaceuticals Ltd.

BALAXI

• NSE: BALAXI • Delayed

26.63INR -0.2%

0.2792 USD

As of 6 June 2026, Balaxi Pharmaceuticals Ltd. has a market cap of $15.38M USD, ranking #38832 globally and #2858 in India. It ranks #3465 in the Healthcare sector, and #162 in the Medical Distribution industry.

Global Rank

38832

Country Rank

2858

Sector Rank

3465

Industry Rank

162

Key Stats

Market Cap

$15.38MUSD

1.47B INR

Enterprise Value

$17.3MUSD

1.65B INR

Revenue (TTM)

$28.8MUSD

2.76B INR

EBITDA (TTM)

$2.14MUSD

204.1M INR

Net Income (TTM)

$986.08KUSD

94.42M INR

EBITDA Margin

7.4%

Profit Margin

3.4%

PE Ratio

15.3

PS Ratio

0.5

PB Ratio

0.6

EV/EBITDA

8.0

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Medical Distribution

Employees

600

Founded

1942

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-2.2%	62%	6.1%	-36%	-0.7%	-54%	-75%	-77%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	BALAXI Balaxi Pharmaceuticals Ltd ISIN: INE618N01022 Shares Out.: Shares Outstanding: 55.208M¹ Shares Float: 16.36M² TV: TradingView: NSE: BALAXI SA: Stock Analysis: NSE: BALAXI YF: Yahoo Finance: BALAXI.NS GF: Google Finance: NSE: BALAXI BA: Barron's: BALAXI MS: Morningstar: XNSE: BALAXI	26.63 INR	TV: TradingView: NSE: BALAXI SA: Stock Analysis: NSE: BALAXI YF: Yahoo Finance: BALAXI.NS GF: Google Finance: NSE: BALAXI BA: Barron's: BALAXI MS: Morningstar: XNSE: BALAXI

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Balaxi Pharmaceuticals Ltd.

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.

Similar Companies

Industry: Medical Distribution (India)

Name	Market Cap (USD) diff.	PE	Country
Entero Healthcare Solutions Ltd. NSE: ENTERO	$541.39M 51.84B INR 3K%	46.1	India
Aptus Pharma Ltd. BSE: APPL	$33.19M 3.18B INR 116%	-	India
Bijoy Hans Ltd. BSE: 524723	$27.7M 2.65B INR 80%	-	India
Everest Organics Ltd. BSE: 524790	$27.37M 2.62B INR 78%	44.6	India
VijayPD Ceutical Ltd. NSE: VIJAYPD	$21.22M 2.03B INR 38%	27.1	India
Rama Vision Ltd. BSE: 523289	$19.35M 1.85B INR 26%	36.3	India

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 655K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 394K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 310K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 55K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 49K%	7.2	China
Galenica AG SIX: GALE	$5.32B 4.2B CHF 35K%	23.0	Switzerland

chevron_leftBack